Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Third party research

Nolato: Resilient Medical exposure in a chaotic market - ABG

Nolato

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
Q1e: a solid quarter with EBITA up 11% y-o-y
Higher estimates following ambitious new targets
Medical (~60% of EBITA) should be resilient in a downturn


Q1e: a solid quarter with EBITA up 11% y-o-y

We expect Nolato to report Q1 net sales of SEK 2,527m, up 3% y-o-y (+3% organic), and EBITA of SEK 264m, for a margin of 10.4% (9.7%); we are roughly in line with FactSet consensus. The cyclical fears driven by tariffs started in April and should not impact the Q1 numbers. As such, we expect a solid quarter in both segments, but we see some increased risk in Engineered in subsequent quarters in case of a general slowdown in economic activity. Medical, however, should be more resilient.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.